⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2229984 | 0.94 | — | — | |
| SCHEMBL5909605 | 0.94 | — | — | |
| SCHEMBL2778576 | 0.89 | — | — | |
| SCHEMBL513824 | 0.89 | — | — | |
| SCHEMBL2126834 | 0.89 | — | — | |
| SCHEMBL13835190 | 0.84 | — | — | |
| SCHEMBL19878898 | 0.84 | — | — | |
| SCHEMBL13836035 | 0.84 | MGLL (0.38) | — | |
| SCHEMBL1428237 | 0.84 | MGLL (0.38) | — | |
| SCHEMBL3273654 | 0.84 | MGLL (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232114-A | SOS1 degradation agent and preparation method and application thereof | 上海领泰生物医药科技有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115232111-A | SOS1 degradation agent and preparation method and application thereof | 上海领泰生物医药科技有限公司 | 2022-10-25 | — | — | CN | claimed |
| WO-2024047674-A1 | MANGANESE BASED CATALYST, ITS PROCESS OF PREPARATION AND THEIR USE IN PROCESS OF HYDROGENATION REACTIONS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024042544-A1 | NICKEL-BASED CATALYSTS FOR THE SELECTIVE (DE)HYDROGENATIVE COUPLING OF BENZYL ALCOHOLS WITH AZOBENZENES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2024-02-29 | — | — | WO | disclosed |
| US-20230286928-A1 | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | EPIGEN BIOSCIENCES, INC. (US) | 2023-09-14 | — | — | US | disclosed |
| EP-3807254-A1 | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | Epigen Biosciences, Inc. (US) | 2021-04-21 | — | — | EP | disclosed |
| EP-2988743-B1 | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | EPIGEN BIOSCIENCES INC (US) | 2020-12-09 | — | — | EP | disclosed |
| EP-3710431-A1 | SUBSTITUTED PYRROLOPYRIMIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME | Aclaris Therapeutics, Inc. (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20200181099-A1 | Heterocyclic Compounds Useful In The Treatment Of Disease | EPIGEN BIOSCIENCES, INC. (US) | 2020-06-11 | — | — | US | disclosed |
| US-10570103-B2 | Heterocyclic compounds useful in the treatment of disease | EPIGEN BIOSCIENCES, INC. (US) | 2020-02-25 | — | — | US | disclosed |
| US-20190135767-A1 | Heterocyclic Compounds Useful In The Treatment Of Disease | EPIGEN BIOSCIENCES, INC. (US) | 2019-05-09 | — | — | US | disclosed |
| EP-3116486-A2 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | Capon, Daniel J. (US) | 2017-01-18 | — | — | EP | disclosed |
| EP-2988743-A2 | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | Epigen Biosciences, Inc. (US) | 2016-03-02 | — | — | EP | disclosed |
| US-20160024031-A1 | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | EPIGEN BIOSCIENCES, INC. (US) | 2016-01-28 | — | — | US | disclosed |
| EP-2958558-A2 | METHODS AND COMPOSITIONS FOR TREATING LEUKEMIA | Golden Biotechnology Corporation (US) | 2015-12-30 | — | — | EP | disclosed |
| WO-2015138907-A2 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | CAPON DANIEL J (US) | 2015-09-17 | — | — | WO | disclosed |
| US-20150259592-A1 | Coated And Cured Proppants | PREFERRED TECHNOLOGY, LLC | 2015-09-17 | — | — | US | disclosed |
| WO-2014145873-A2 | HETEROCYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DISEASE | EPIGEN BIOSCIENCES, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014130619-A2 | METHODS AND COMPOSITIONS FOR TREATING LEUKEMIA | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2014-08-28 | — | — | WO | disclosed |
| EP-0537338-A1 | THERMALLY STABLE COMPOSITIONS AND LUBRICANTS AND FUNCTIONAL FLUIDS CONTAINING THE SAME. | LUBRIZOL CORP (US) | 1993-04-21 | — | — | EP | disclosed |